BSC Medical - Gateway to your medical needsNew and Used Medical Equipment

Latest News

OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Acute Lymphoblastic Leukemia (ALL)
Wed, 19 Sep 2018 12:19:58 GMT

Second Orphan Drug Designation for OBI-3424, a novel first-in-class targeted therapy for solid and liquid tumors that express aldo-keto reductase 1c3 (AKR1C3) enzyme TAIPEI, Taiwan, Sept. 19, 2018 -- (Healthcare Sales & Marketing Network) -- OBI Pharma...
Biopharmaceuticals, Oncology, FDA
OBI Pharma, Acute Lymphoblastic Leukemia, Adagloxad Simolenin

Oculis Elects Anthony Rosenberg and David A. Weber - Veterans of the Global Pharmaceutical and Eye-care Industries - to its Board of Directors
Wed, 19 Sep 2018 12:15:15 GMT

LAUSANNE, Switzerland, September 19, 2018 -- (Healthcare Sales & Marketing Network) -- Oculis, a clinical-stage biotechnology company developing next-generation topical treatments for acute and chronic back- and front-of-the-eye diseases, announces the ap...
Biopharmaceuticals, Ophthalmology, Personnel
Oculis , Diabetic Macular Edema

Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
Tue, 18 Sep 2018 22:28:49 GMT

For the first time, early-stage breast cancer patients and their physicians in China can access clinically validated and prospectively proven tests for breast cancer risk of recurrence and molecular subtyping IRVINE, Calif. and AMSTERDAM and BEIJING, Se...
Diagnostics, Personalized Medicine, Oncology, Product Launch
Agendia, MammaPrint, breast cancer

1st Wireless, Handheld, FDA-approved Ultrasound Device to Offer Live Demos at FMX (Family Medicine Experience) 2018, Booth #722
Tue, 18 Sep 2018 15:39:11 GMT

Wireless, app-based technology is positioning the ultrasound to become as ubiquitous as a stethoscope for general practitioners ROSEVILLE, Calif., Sept. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Healcerion today announced the SONON 300L wil...
Devices, Product Launch
Healcerion, wireless, ultrasound imaging, ultrasound, smartphone

TranS1(R) Announces NICE Guidance for Approval of AxiaLIF(R) in the UK's National Health System (NHS)
Tue, 18 Sep 2018 15:32:57 GMT

NICE's Positive Recommendation for the Transaxial Interbody Lumbosacral Fusion describing the Anterior Retroperitoneal Presacral Approach is based on AxiaLIF clinical evidence WILMINGTON, N.C., Sept. 18, 2018 -- (Healthcare Sales & Marketing Network) -...
Devices, Orthopaedic, Neurosurgery, Reimbursement
TranS1, AxiaLIF, lumbosacral fusion

Anti-migraine Head Patch - HeadaTerm - Receives FDA Clearance
Mon, 17 Sep 2018 15:25:55 GMT

VANCOUVER, British Columbia, Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- WAT Medical's innovative technology to treat all primary headaches, HeadaTerm, received its FDA clearance in September 2018. This product, already approved by CE, HC,...
Devices, Neurology, FDA
WAT Medical Enterprise, HeadaTerm, neuromodulation, migraine

U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
Mon, 17 Sep 2018 15:22:06 GMT

U.S. Commercial Launch of Cash-Pay Product Anticipated in Mid-2019 DULUTH, Ga., Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that the U...
Devices, Dermatology, FDA
Sebacia, Sebacia Microparticles, acne

Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin(R)) In Canada
Mon, 17 Sep 2018 15:19:27 GMT

SAN DIEGO, Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Halozyme Therapeutics, Inc. (NASDAQ :HALO ) today announced that Roche has received approval from Health Canada for a subcutaneous (SC) formulation of trastuzumab (Herceptin SC) for th...
Biopharmaceuticals, Oncology, Regulatory
Halozyme Therapeutics, Genentech, trastuzumab, Herceptin, hyaluronidase

Livongo Announces First Cellular-Enabled Blood Pressure Monitoring System in U.S.
Mon, 17 Sep 2018 15:17:35 GMT

Cellular Connectivity Enables Home Checking & Reporting, Reduces 'White Coat' Issues MOUNTAIN VIEW, Calif., Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Livongo Health, the leading consumer digital health company empowering people with c...
Devices, Cardiology, Product Launch
Livongo Health, Cellular-Enabled, Blood Pressure Monitor

CartiHeal Performs First Hungarian Case in the Agili-C(TM) Implant IDE Multinational Pivotal Study
Mon, 17 Sep 2018 12:50:50 GMT

KFAR SABA, Israel and BUDAPEST, Hungary, Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- CartiHeal, developer of the Agili-C implant for the treatment of joint surface lesions, and the Principle Investigator Professor László Hang...
Devices, Orthopaedic
CartiHeal, Agili-C , osteochondral defects, osteoarthritic joints

Source: HSMN NewsFeed